Clinical Trial Update: Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy [Phase 2, Phase 3]

View source ↗

Summary

The document updates a Phase 2/3 clinical trial aimed at preventing thrombocytopenia after first-line chemotherapy in non-small cell lung cancer. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Chinese Society of Lung Cancer | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2, Phase 3 | Status: TERMINATED